Why the study?
What is the validity of diagnostic codes for hypertrophic cardiomyopathy in a Swedish regional cohort?
What is the validity of diagnostic codes for hypertrophic cardiomyopathy in a Swedish regional cohort?
One-third of patients with diagnostic codes for hypertrophic cardiomyopathy in a Swedish regional cohort were misclassified, highlighting the need for caution when interpreting registry data.
HCM registry diagnoses warrant verification; leaves open misclassification extent in other cohorts.
PURPOSE: To validate diagnostic codes for hypertrophic cardiomyopathy (HCM), analyze misclassfications, and estimate the prevalence of HCM in an unselected Swedish regional cohort. PATIENTS AND METHODS: Using the hospitals' electronic medical records (used for the Swedish National Patient Register), we identified 136 patients from 2006 to 2016 with the HCM-related codes 142.1 and 142.2 (International Classification of Diseases). RESULTS: =0.118). CONCLUSION: One-third of patients diagnosed as HCM are misclassified, so registry data should be interpreted with caution. A correct diagnosis is important for decision-making and implementation of optimal HCM care; efforts should be made to increase awareness of HCM and diagnostic competence throughout the health care system.
No takes yet. Share an insight, caveat, or question.
Magnusson et al. (2017) studied this question.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: